Click for best price
Active Tuberculosis Treatment Market Size, Share 2024
The global Active Tuberculosis Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Rifampin Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Active Tuberculosis Treatment include Lupin, Sanofi, Pfizer Inc., FRESENIUS SE & Co, KGaA (Fresenius Kabi), Johnson & Johnson, Novartis AG, Macleods Pharmaceuticals Ltd. and ANI Pharmaceuticals, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Active Tuberculosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Tuberculosis Treatment. This report contains market size and forecasts of Active Tuberculosis Treatment in global, including the following market information:
Global Active Tuberculosis Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Active Tuberculosis Treatment Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Active Tuberculosis Treatment companies in 2023 (%)
We surveyed the Active Tuberculosis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Tuberculosis Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Active Tuberculosis Treatment Market Segment Percentages, by Type, 2023 (%)
Rifampin
Pyrazinamide
Ethambutol
Global Active Tuberculosis Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Active Tuberculosis Treatment Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Pharmacies
Global Active Tuberculosis Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Active Tuberculosis Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Tuberculosis Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Active Tuberculosis Treatment revenues share in global market, 2023 (%)
Key companies Active Tuberculosis Treatment sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Active Tuberculosis Treatment sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Sanofi
Pfizer Inc.
FRESENIUS SE & Co
KGaA (Fresenius Kabi)
Johnson & Johnson
Novartis AG
Macleods Pharmaceuticals Ltd.
ANI Pharmaceuticals, Inc.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Tuberculosis Treatment, market overview.
Chapter 2: Global Active Tuberculosis Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Active Tuberculosis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Tuberculosis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Active Tuberculosis Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Active Tuberculosis Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Active Tuberculosis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Tuberculosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Tuberculosis Treatment Overall Market Size
2.1 Global Active Tuberculosis Treatment Market Size: 2023 VS 2030
2.2 Global Active Tuberculosis Treatment Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Active Tuberculosis Treatment Sales: 2019-2030
3 Company Landscape
3.1 Top Active Tuberculosis Treatment Players in Global Market
3.2 Top Global Active Tuberculosis Treatment Companies Ranked by Revenue
3.3 Global Active Tuberculosis Treatment Revenue by Companies
3.4 Global Active Tuberculosis Treatment Sales by Companies
3.5 Global Active Tuberculosis Treatment Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Active Tuberculosis Treatment Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Active Tuberculosis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Tuberculosis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Active Tuberculosis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Tuberculosis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Tuberculosis Treatment Market Size Markets, 2023 & 2030
4.1.2 Rifampin
4.1.3 Pyrazinamide
4.1.4 Ethambutol
4.2 By Type - Global Active Tuberculosis Treatment Revenue & Forecasts
4.2.1 By Type - Global Active Tuberculosis Treatment Revenue, 2019-2024
4.2.2 By Type - Global Active Tuberculosis Treatment Revenue, 2025-2030
4.2.3 By Type - Global Active Tuberculosis Treatment Revenue Market Share, 2019-2030
4.3 By Type - Global Active Tuberculosis Treatment Sales & Forecasts
4.3.1 By Type - Global Active Tuberculosis Treatment Sales, 2019-2024
4.3.2 By Type - Global Active Tuberculosis Treatment Sales, 2025-2030
4.3.3 By Type - Global Active Tuberculosis Treatment Sales Market Share, 2019-2030
4.4 By Type - Global Active Tuberculosis Treatment Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Active Tuberculosis Treatment Market Size, 2023 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores and Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Active Tuberculosis Treatment Revenue & Forecasts
5.2.1 By Application - Global Active Tuberculosis Treatment Revenue, 2019-2024
5.2.2 By Application - Global Active Tuberculosis Treatment Revenue, 2025-2030
5.2.3 By Application - Global Active Tuberculosis Treatment Revenue Market Share, 2019-2030
5.3 By Application - Global Active Tuberculosis Treatment Sales & Forecasts
5.3.1 By Application - Global Active Tuberculosis Treatment Sales, 2019-2024
5.3.2 By Application - Global Active Tuberculosis Treatment Sales, 2025-2030
5.3.3 By Application - Global Active Tuberculosis Treatment Sales Market Share, 2019-2030
5.4 By Application - Global Active Tuberculosis Treatment Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Active Tuberculosis Treatment Market Size, 2023 & 2030
6.2 By Region - Global Active Tuberculosis Treatment Revenue & Forecasts
6.2.1 By Region - Global Active Tuberculosis Treatment Revenue, 2019-2024
6.2.2 By Region - Global Active Tuberculosis Treatment Revenue, 2025-2030
6.2.3 By Region - Global Active Tuberculosis Treatment Revenue Market Share, 2019-2030
6.3 By Region - Global Active Tuberculosis Treatment Sales & Forecasts
6.3.1 By Region - Global Active Tuberculosis Treatment Sales, 2019-2024
6.3.2 By Region - Global Active Tuberculosis Treatment Sales, 2025-2030
6.3.3 By Region - Global Active Tuberculosis Treatment Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Active Tuberculosis Treatment Revenue, 2019-2030
6.4.2 By Country - North America Active Tuberculosis Treatment Sales, 2019-2030
6.4.3 US Active Tuberculosis Treatment Market Size, 2019-2030
6.4.4 Canada Active Tuberculosis Treatment Market Size, 2019-2030
6.4.5 Mexico Active Tuberculosis Treatment Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Active Tuberculosis Treatment Revenue, 2019-2030
6.5.2 By Country - Europe Active Tuberculosis Treatment Sales, 2019-2030
6.5.3 Germany Active Tuberculosis Treatment Market Size, 2019-2030
6.5.4 France Active Tuberculosis Treatment Market Size, 2019-2030
6.5.5 U.K. Active Tuberculosis Treatment Market Size, 2019-2030
6.5.6 Italy Active Tuberculosis Treatment Market Size, 2019-2030
6.5.7 Russia Active Tuberculosis Treatment Market Size, 2019-2030
6.5.8 Nordic Countries Active Tuberculosis Treatment Market Size, 2019-2030
6.5.9 Benelux Active Tuberculosis Treatment Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Active Tuberculosis Treatment Revenue, 2019-2030
6.6.2 By Region - Asia Active Tuberculosis Treatment Sales, 2019-2030
6.6.3 China Active Tuberculosis Treatment Market Size, 2019-2030
6.6.4 Japan Active Tuberculosis Treatment Market Size, 2019-2030
6.6.5 South Korea Active Tuberculosis Treatment Market Size, 2019-2030
6.6.6 Southeast Asia Active Tuberculosis Treatment Market Size, 2019-2030
6.6.7 India Active Tuberculosis Treatment Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Active Tuberculosis Treatment Revenue, 2019-2030
6.7.2 By Country - South America Active Tuberculosis Treatment Sales, 2019-2030
6.7.3 Brazil Active Tuberculosis Treatment Market Size, 2019-2030
6.7.4 Argentina Active Tuberculosis Treatment Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Active Tuberculosis Treatment Sales, 2019-2030
6.8.3 Turkey Active Tuberculosis Treatment Market Size, 2019-2030
6.8.4 Israel Active Tuberculosis Treatment Market Size, 2019-2030
6.8.5 Saudi Arabia Active Tuberculosis Treatment Market Size, 2019-2030
6.8.6 UAE Active Tuberculosis Treatment Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Lupin
7.1.1 Lupin Company Summary
7.1.2 Lupin Business Overview
7.1.3 Lupin Active Tuberculosis Treatment Major Product Offerings
7.1.4 Lupin Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.1.5 Lupin Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Active Tuberculosis Treatment Major Product Offerings
7.2.4 Sanofi Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Active Tuberculosis Treatment Major Product Offerings
7.3.4 Pfizer Inc. Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 FRESENIUS SE & Co
7.4.1 FRESENIUS SE & Co Company Summary
7.4.2 FRESENIUS SE & Co Business Overview
7.4.3 FRESENIUS SE & Co Active Tuberculosis Treatment Major Product Offerings
7.4.4 FRESENIUS SE & Co Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.4.5 FRESENIUS SE & Co Key News & Latest Developments
7.5 KGaA (Fresenius Kabi)
7.5.1 KGaA (Fresenius Kabi) Company Summary
7.5.2 KGaA (Fresenius Kabi) Business Overview
7.5.3 KGaA (Fresenius Kabi) Active Tuberculosis Treatment Major Product Offerings
7.5.4 KGaA (Fresenius Kabi) Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.5.5 KGaA (Fresenius Kabi) Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Active Tuberculosis Treatment Major Product Offerings
7.6.4 Johnson & Johnson Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Active Tuberculosis Treatment Major Product Offerings
7.7.4 Novartis AG Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.7.5 Novartis AG Key News & Latest Developments
7.8 Macleods Pharmaceuticals Ltd.
7.8.1 Macleods Pharmaceuticals Ltd. Company Summary
7.8.2 Macleods Pharmaceuticals Ltd. Business Overview
7.8.3 Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Major Product Offerings
7.8.4 Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.8.5 Macleods Pharmaceuticals Ltd. Key News & Latest Developments
7.9 ANI Pharmaceuticals, Inc.
7.9.1 ANI Pharmaceuticals, Inc. Company Summary
7.9.2 ANI Pharmaceuticals, Inc. Business Overview
7.9.3 ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Major Product Offerings
7.9.4 ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.9.5 ANI Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Otsuka Pharmaceutical Co., Ltd.
7.10.1 Otsuka Pharmaceutical Co., Ltd. Company Summary
7.10.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
7.10.3 Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Major Product Offerings
7.10.4 Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.10.5 Otsuka Pharmaceutical Co., Ltd. Key News & Latest Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.11.2 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Sales and Revenue in Global (2019-2024)
7.11.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Global Active Tuberculosis Treatment Production Capacity, Analysis
8.1 Global Active Tuberculosis Treatment Production Capacity, 2019-2030
8.2 Active Tuberculosis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Tuberculosis Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Tuberculosis Treatment Supply Chain Analysis
10.1 Active Tuberculosis Treatment Industry Value Chain
10.2 Active Tuberculosis Treatment Upstream Market
10.3 Active Tuberculosis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Tuberculosis Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Active Tuberculosis Treatment in Global Market
Table 2. Top Active Tuberculosis Treatment Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Active Tuberculosis Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Active Tuberculosis Treatment Revenue Share by Companies, 2019-2024
Table 5. Global Active Tuberculosis Treatment Sales by Companies, (K Units), 2019-2024
Table 6. Global Active Tuberculosis Treatment Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Active Tuberculosis Treatment Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Active Tuberculosis Treatment Product Type
Table 9. List of Global Tier 1 Active Tuberculosis Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Tuberculosis Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Active Tuberculosis Treatment Sales (K Units), 2019-2024
Table 15. By Type - Global Active Tuberculosis Treatment Sales (K Units), 2025-2030
Table 16. By Application ? Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Active Tuberculosis Treatment Sales (K Units), 2019-2024
Table 20. By Application - Global Active Tuberculosis Treatment Sales (K Units), 2025-2030
Table 21. By Region ? Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Active Tuberculosis Treatment Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Active Tuberculosis Treatment Sales (K Units), 2019-2024
Table 25. By Region - Global Active Tuberculosis Treatment Sales (K Units), 2025-2030
Table 26. By Country - North America Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Active Tuberculosis Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Active Tuberculosis Treatment Sales, (K Units), 2019-2024
Table 29. By Country - North America Active Tuberculosis Treatment Sales, (K Units), 2025-2030
Table 30. By Country - Europe Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Active Tuberculosis Treatment Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Active Tuberculosis Treatment Sales, (K Units), 2019-2024
Table 33. By Country - Europe Active Tuberculosis Treatment Sales, (K Units), 2025-2030
Table 34. By Region - Asia Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Active Tuberculosis Treatment Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Active Tuberculosis Treatment Sales, (K Units), 2019-2024
Table 37. By Region - Asia Active Tuberculosis Treatment Sales, (K Units), 2025-2030
Table 38. By Country - South America Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Active Tuberculosis Treatment Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Active Tuberculosis Treatment Sales, (K Units), 2019-2024
Table 41. By Country - South America Active Tuberculosis Treatment Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Active Tuberculosis Treatment Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Active Tuberculosis Treatment Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Active Tuberculosis Treatment Sales, (K Units), 2025-2030
Table 46. Lupin Company Summary
Table 47. Lupin Active Tuberculosis Treatment Product Offerings
Table 48. Lupin Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Lupin Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Active Tuberculosis Treatment Product Offerings
Table 52. Sanofi Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Sanofi Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Active Tuberculosis Treatment Product Offerings
Table 56. Pfizer Inc. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. FRESENIUS SE & Co Company Summary
Table 59. FRESENIUS SE & Co Active Tuberculosis Treatment Product Offerings
Table 60. FRESENIUS SE & Co Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. FRESENIUS SE & Co Key News & Latest Developments
Table 62. KGaA (Fresenius Kabi) Company Summary
Table 63. KGaA (Fresenius Kabi) Active Tuberculosis Treatment Product Offerings
Table 64. KGaA (Fresenius Kabi) Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. KGaA (Fresenius Kabi) Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Active Tuberculosis Treatment Product Offerings
Table 68. Johnson & Johnson Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Active Tuberculosis Treatment Product Offerings
Table 72. Novartis AG Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Novartis AG Key News & Latest Developments
Table 74. Macleods Pharmaceuticals Ltd. Company Summary
Table 75. Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Product Offerings
Table 76. Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Macleods Pharmaceuticals Ltd. Key News & Latest Developments
Table 78. ANI Pharmaceuticals, Inc. Company Summary
Table 79. ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Product Offerings
Table 80. ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. ANI Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Otsuka Pharmaceutical Co., Ltd. Company Summary
Table 83. Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Product Offerings
Table 84. Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Otsuka Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 86. Teva Pharmaceutical Industries Ltd. Company Summary
Table 87. Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Product Offerings
Table 88. Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 90. Active Tuberculosis Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 91. Global Active Tuberculosis Treatment Capacity Market Share of Key Manufacturers, 2021-2024
Table 92. Global Active Tuberculosis Treatment Production by Region, 2019-2024 (K Units)
Table 93. Global Active Tuberculosis Treatment Production by Region, 2025-2030 (K Units)
Table 94. Active Tuberculosis Treatment Market Opportunities & Trends in Global Market
Table 95. Active Tuberculosis Treatment Market Drivers in Global Market
Table 96. Active Tuberculosis Treatment Market Restraints in Global Market
Table 97. Active Tuberculosis Treatment Raw Materials
Table 98. Active Tuberculosis Treatment Raw Materials Suppliers in Global Market
Table 99. Typical Active Tuberculosis Treatment Downstream
Table 100. Active Tuberculosis Treatment Downstream Clients in Global Market
Table 101. Active Tuberculosis Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Tuberculosis Treatment Segment by Type in 2023
Figure 2. Active Tuberculosis Treatment Segment by Application in 2023
Figure 3. Global Active Tuberculosis Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Active Tuberculosis Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Active Tuberculosis Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. Active Tuberculosis Treatment Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Active Tuberculosis Treatment Revenue in 2023
Figure 9. By Type - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 11. By Type - Global Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 12. By Type - Global Active Tuberculosis Treatment Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 15. By Application - Global Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 16. By Application - Global Active Tuberculosis Treatment Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Active Tuberculosis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Active Tuberculosis Treatment Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 20. By Region - Global Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 21. By Country - North America Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 22. By Country - North America Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 23. US Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 28. Germany Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. France Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 37. China Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. India Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 43. By Country - South America Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 44. Brazil Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Active Tuberculosis Treatment Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Active Tuberculosis Treatment Sales Market Share, 2019-2030
Figure 48. Turkey Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Active Tuberculosis Treatment Revenue, (US$, Mn), 2019-2030
Figure 52. Global Active Tuberculosis Treatment Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Active Tuberculosis Treatment by Region, 2023 VS 2030
Figure 54. Active Tuberculosis Treatment Industry Value Chain
Figure 55. Marketing Channels
